
    
      This is a single group, single arm, open/nonblinded, non-randomized study. The primary
      outcomes are safety and preliminary efficacy. The InSightec ExAblate 2100 MRgHIFU system is a
      non-invasive thermal ablation device fully integrated with an MR imaging system and used for
      the ablation of soft tissue and bone.The study will reach primary completion 12 months from
      the time the study opens to accrual.
    
  